Concepedia

Charlotte De Bondt

CD

Statistics

Publications

4

Citations

207

H-Index

4

Active since

2020

Affiliations

Antwerp University Hospital(Current)

Hospital Universitari i Politècnic La Fe

University of Antwerp

Hospital Universitario Son Espases

Mirati Therapeutics (United States)

Charlotte De Bondt is an author at Antwerp University Hospital specializing in medicine, drug discovery, and oncology.

Top concepts

Publications per year

2020–2025

4

Publications

4

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

Isabelle Opitz, Arnaud Scherpereel, Thierry Berghmans et al. · European Journal of Cardio-Thoracic Surgery · 2020 · 110 citations · Full text

KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRAS<sup>G12C</sup> mutation.

Tony Mok, Wenxiu Yao, M. Duruisseaux et al. · Journal of Clinical Oncology · 2024 · 64 citations

, , +19

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial

Fabrice Barlési, Wenxiu Yao, M. Duruisseaux et al. · The Lancet · 2025 · 17 citations

Pseudo-acute kidney injury secondary to tepotinib

Veerle Wijtvliet, Laurence Roosens, Charlotte De Bondt et al. · Clinical Kidney Journal · 2022 · 16 citations · Full text

, , +5

1–4 of 4